Zelira Therapeutics Ltd

Research Zelira Therapeutics Ltd (ZLD) on Bullrun: market cap AUD 5.95M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerZLD
• ExchangeAU
• CountryAustralia
• SectorHealthcare
• IndustryBiotechnology
• CurrencyAUD
• Market capAUD 5.95M
• Financial periodFY2025
• RevenueAUD 656
• Revenue growth-99.3%
• Net income-AUD 3.63M
• Free cash flow-AUD 4.91M
• Gross margin-1245.4%

Valuation Snapshot

latest market cap is AUD 5.95M.

About Zelira Therapeutics Ltd

Zelira Therapeutics Limited, a biopharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. It offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops ZENIVOL, a cannabinoid drug for the treatment of chronic insomnia.

Frequently asked questions

What is Zelira Therapeutics Ltd's market cap?

Zelira Therapeutics Ltd's market capitalization is AUD 5.95M.

What does Zelira Therapeutics Ltd do?

Zelira Therapeutics Limited, a biopharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States.